<scp>MiR</scp> ‐210‐3p is upregulated in diabetic peripheral neuropathy and may be involved in the progression of the disease by targeting brain‐derived neurotrophic factor

20260 citationsJournal Articlegold Open Access

Authors

Yafei Zhao · First Hospital of Shijiazhuang

Liu Wang · Tri-Service General Hospital Songshan Branch

Abstract

MiR-210-3p serves as a potential diagnostic biomarker for DPN and regulates Schwann cell function via targeting BDNF, providing novel insights into DPN pathogenesis and therapeutic targets.

Topics & Keywords

Diabetic Foot Ulcer Assessment and Management Nerve injury and regeneration Pain Mechanisms and Treatments

Publication Details

Published in: Journal of Diabetes Investigation

Volume 17, Issue 4, pp. 672-680

DOI: 10.1111/jdi.70199

Field-Weighted Citation Impact: 0.00

Command Palette

<scp>MiR</scp> ‐210‐3p is upregulated in diabetic peripheral neuropathy and may be involved in the progression of the disease by targeting brain‐derived neurotrophic factor

Authors

Abstract

Topics & Keywords

Publication Details